T. Waehre

Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.

K. Arnesen, S. Frøland, P. Aukrust, 2003, Journal of the American College of Cardiology.

Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation.

G. Hansson, P. Olofsson, K. Endresen, 2006, Journal of the American College of Cardiology.

High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.

B. Fevang, S. Frøland, P. Aukrust, 2008, Cardiovascular research.

Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells – potential role of prostaglandin E2

K. Taskén, S. Frøland, P. Aukrust, 2004, Thrombosis and Haemostasis.

8-isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases.

S. Tonstad, P. Aukrust, J. Damås, 2003, Cardiovascular research.

Potential anti-inflammatory role of activin A in acute coronary syndromes.

K. Endresen, S. Frøland, T. Ueland, 2004, Journal of the American College of Cardiology.

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy.

J. Kastelein, S. Frøland, T. Ueland, 2003, Journal of the American College of Cardiology.

Role of interleukin-10 in atherogenesis and plaque stabilization.

P. Aukrust, A. Yndestad, B. Halvorsen, 2006, Future cardiology.